首页 | 本学科首页   官方微博 | 高级检索  
检索        

食管癌综合治疗与单一手术治疗的比较
引用本文:王春利,丁悌,常林宝,赵进明,郭慧.食管癌综合治疗与单一手术治疗的比较[J].中华肿瘤杂志,2001,23(3):254-255.
作者姓名:王春利  丁悌  常林宝  赵进明  郭慧
作者单位:山西省肿瘤医院胸外科
摘    要:目的评价Ⅱ、Ⅲ期食管癌术前化疗的价值。方法对50例Ⅱ、Ⅲ期食管癌患者进行以顺铂为主的联合化疗,并与同期内50例单纯手术患者进行比较分析,进一步探讨提高Ⅱ、Ⅲ期食管癌患者的远期疗效。结果单纯手术组5年生存率为32.0%,术前化疗组5年生存率为46.0%,两组差异有显著性(P<0.05)。结论术前化疗复发率及转移率低,术前化疗组5年生存率高于单纯手术组。

关 键 词:食管癌  综合疗法  外科手术
修稿时间:1999年9月10日

A randomized clinical study of preoperative chemotherapy for esophageal carcinoma
WANG Chunli,DING Ti,CHANG Linbao,et al..A randomized clinical study of preoperative chemotherapy for esophageal carcinoma[J].Chinese Journal of Oncology,2001,23(3):254-255.
Authors:WANG Chunli  DING Ti  CHANG Linbao  
Institution:Shanxi Tumor Hospital, Taiyuan 030013, China.
Abstract:OBJECTIVE: To evaluate the effect of preoperative chemotherapy on the prognosis of stage II or III patients with esophageal carcinoma. METHODS: From February 1991 to June 1994, 50 patients with stage II, III esophageal carcinoma were treated with preoperative combination (CDDP) chemotherapy and compared with 50 patients received operation alone. RESULTS: The 5-year survival rate of the operation group and preoperative chemotherapy group was 32% and 46%, respectively. The difference was statistically significant. CONCLUSION: Preoperative chemotherapy improves survival of surgically treated esophageal cancer patients.
Keywords:Esophageal neoplasms/therapy  Esophageal neoplasms/surgery  Adjutant therapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号